Cyhoeddiadau

Adroddiad blynyddol 2022/23

Adroddiad blynyddol HCEC 2022-23

Bob blwyddyn rydym yn adrodd ar ein gweithgareddau i’n cyllidwr, Ymchwil Iechyd a Gofal Cymru. Yma gallwch ddysgu am yr ystod o arbenigedd economeg iechyd rydym yn ei ddarparu a dysgu mwy am ein hastudiaethau achos rhagorol.

Gweld Adroddiad Blynyddol HCEC 2022-23 

 

Adroddiadau blaenorol:

Gweler isod am ein cyhoeddiadau allweddol

‘What You See is All There is’: The Importance of Heuristics in Cost-Benefit Analysis (CBA) and Social Return on Investment (SROI) in the Evaluation of Public Health Interventions.

Edwards, R. T., & Lawrence, C. L. (2021). ‘What You See is All There is’: The Importance of Heuristics in Cost-Benefit Analysis (CBA) and Social Return on Investment (SROI) in the Evaluation of Public Health Interventions. Applied Health Economics and Health Policy, 19(5), 653–664.

2021

Identifying safe care processes when GPs work in or alongside emergency departments: a realist evaluation. 

Cooper, A., Carson-Stevens, A., Edwards, M., Davies, F., Donaldson, L. J., Anderson, P., ... & Edwards, A. (2021). Identifying safe care processes when GPs work in or alongside emergency departments: a realist evaluation. British Journal of General Practice, 71(713), e931-e940.

2021

J02 Trident: investigating the safety and feasibility of fetal cell transplants in Huntingtons disease.

Drew, C. J., Sharouf, F., Randell, E., Brookes-Howell, L., Smallman, K., Sewell, B., ... & Rosser, A. (2021). J02 Trident: investigating the safety and feasibility of fetal cell transplants in huntingtons disease. Journal of Neurology, Neurosurgery & Psychiatry 2021;92:A53-A54

2021

Randomised feasibility study of prehospital recognition and antibiotics for emergency patients with sepsis (PhRASe). 

Jones, J., Allen, S., Davies, J., Driscoll, T., Ellis, G., Fegan, G., …Sewell, B…... & Moore, C. (2021). Randomised feasibility study of prehospital recognition and antibiotics for emergency patients with sepsis (PhRASe). Scientific reports, 11(1), 1-10.

2021

Economic model to examine the cost-effectiveness of FlowOx home therapy compared to standard care in patients with peripheral artery disease.

Ezeofor, V. S., Bray, N., Bryning, L., Hashmi, F., Hoel, H., Parker, D., & Edwards, R. T. (2021). Economic model to examine the cost-effectiveness of FlowOx home therapy compared to standard care in patients with peripheral artery disease. PLoS ONE, 16(1 January), 1–20.

2021

Development of the MobQoL patient reported outcome measure for mobility-related quality of life.

Bray, N., Spencer, L. H., Tuersley, L., & Edwards, R. T. (2021). Development of the MobQoL patient reported outcome measure for mobility-related quality of life. Disability and Rehabilitation, 43(23), 3395–3404.

2021

Have infection control and prevention measures resulted in any adverse outcomes for care home and domiciliary care residents and staff?

Spencer, L. H., Hartfiel, N., Hendry, A., Anthony, B., Makanjuola, A., Bray, N., Hughes, D.A., Wilkinson, C, Fitzsimmons, D & Edwards, R.T. (November 2021) Have infection control and prevention measures resulted in any adverse outcomes for care home and domiciliary care residents and staff? Report number – RR_00018 (November 2021). Wales COVID-19 Evidence Centre

2021

Which innovations can improve timeliness of investigations and address the backlog in endoscopy for patients with potential symptoms of upper and lower Gastrointestinal (GI) cancers?

Hendry, A., Anthony B.F., Charles, J.M., Hartfiel, N., Roberts, J., Spencer, L.H., Bray, N., Wilkinson, C & Edwards, R.T. (August 2021). Which innovations can improve timeliness of investigations and address the backlog in endoscopy for patients with potential symptoms of upper and lower Gastrointestinal (GI) cancers? RR_00003. (August 2021) 

2021